← All patents

US20220118015A1

Modified il-12 t cell therapy for the treatment of cancer

University of Texas System

Abstract

Provided herein are chimeric antigen receptor (CAR)-like constructs comprising tumor-targeted and membrane-anchored IL-12. Also provided herein are T cells expressing the CAR-like IL-12 construct. Further, methods of treating cancer comprising administering T cells expressing CAR-like IL-12 are …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Shulin Li
Priority date
February 01, 2019
Filing date
January 31, 2020
Publication date
April 21, 2022
Language
en
Metadata fetched
August 29, 2026 00:29